Suppr超能文献

NRAS 异构体在中国黑色素瘤患者中的预后作用。

Prognostic role of NRAS isoforms in Chinese melanoma patients.

机构信息

Department of Oncology, Henan Provincial People's Hospital, Zhengzhou.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China.

出版信息

Melanoma Res. 2019 Jun;29(3):263-269. doi: 10.1097/CMR.0000000000000557.

Abstract

Neuroblastoma rat-sarcoma viral oncogene homolog (NRAS) isoforms are expressed in melanoma tumor tissues, which have been described in Caucasian melanoma. However, the status and the clinical significance of NRAS isoforms in the Asian population have not been investigated on a large scale. We examined the expression levels of NRAS isoforms of 140 melanoma samples using quantitative real-time PCR. Furthermore, the relationship of mRNA expression of NRAS isoforms to clinicopathological characteristics and survival of patients was analyzed. Statistical analysis showed that NRAS isoform 2 expression was correlated with melanoma subtypes (P=0.007), and NRAS isoform 4 expression was correlated with tumor thickness (P=0.031) and clinical stage (P=0.006). The median overall survival for patients with high expression of NRAS isoform 3 was significantly shorter than that for patients with low expression of NRAS isoform 3 (P=0.007). In addition, high expression of NRAS isoform 5 was associated with a worse prognosis (P=0.049 and 0.002 for overall survival and disease-free survival, respectively). Multivariate Cox regression analysis showed that high expression levels of NRAS isoform 3 and isoform 5 were independent poor prognostic factors for patients. Our results indicated that the mRNA expressions of NRAS isoform 3 and isoform 5 may be novel indicators of the prognosis of Chinese melanoma patients.

摘要

神经母细胞瘤大鼠肉瘤病毒癌基因同源物 (NRAS) 异构体在黑色素瘤肿瘤组织中表达,这在白种人黑色素瘤中已有描述。然而,NRAS 异构体在亚洲人群中的状态和临床意义尚未在大规模研究中进行调查。我们使用定量实时 PCR 检查了 140 个黑色素瘤样本中 NRAS 异构体的表达水平。此外,还分析了 NRAS 异构体的 mRNA 表达与患者的临床病理特征和生存之间的关系。统计分析表明,NRAS 异构体 2 的表达与黑色素瘤亚型相关(P=0.007),NRAS 异构体 4 的表达与肿瘤厚度(P=0.031)和临床分期(P=0.006)相关。高表达 NRAS 异构体 3 的患者中位总生存期明显短于低表达 NRAS 异构体 3 的患者(P=0.007)。此外,高表达 NRAS 异构体 5 与预后不良相关(P=0.049 和 0.002 分别用于总生存期和无病生存期)。多变量 Cox 回归分析表明,高表达 NRAS 异构体 3 和异构体 5 是患者独立的不良预后因素。我们的结果表明,NRAS 异构体 3 和异构体 5 的 mRNA 表达可能是中国黑色素瘤患者预后的新指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验